Biovail Settles Ongoing Patent Litigation Over Wellbutrin XL With Generic Firms
This article was originally published in The Pink Sheet Daily
Executive Summary
Generic drug makers will continue to market the 300 mg dose of the GlaxoSmithKline antidepressant, but the 150 mg strength will not go generic until 2008.